ReP USP - Resultado da busca

Artigo de periodico
Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy (2019)
Schmidt, Andre ; Romano, Minna Moreira Dias ; Marin Neto, José Antonio; Rao-Melacini, Purnima; Rassi, Anis; Mattos, Antônio; Avezum Junior, Álvaro ; Villena, Erick; Sosa-Estani, Sergio; Bonilla, Rina; Yusuf, Salim; Morillo, Carlos A.; Maciel, Benedito Carlos
Source: Journal of the American Society of Echocardiography. Unidade: FMRP
Subjects: MIOCARDIOPATIA CONGESTIVA, ECOCARDIOGRAFIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHMIDT, Andre et al. Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy. Journal of the American Society of Echocardiography, v. 32, n. 2, p. 286-295, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.echo.2018.09.006. Acesso em: 15 nov. 2024.
APA
Schmidt, A., Romano, M. M. D., Marin Neto, J. A., Rao-Melacini, P., Rassi, A., Mattos, A., et al. (2019). Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy. Journal of the American Society of Echocardiography, 32( 2), 286-295. doi:10.1016/j.echo.2018.09.006
NLM
Schmidt A, Romano MMD, Marin Neto JA, Rao-Melacini P, Rassi A, Mattos A, Avezum Junior Á, Villena E, Sosa-Estani S, Bonilla R, Yusuf S, Morillo CA, Maciel BC. Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy [Internet]. Journal of the American Society of Echocardiography. 2019 ; 32( 2): 286-295.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.echo.2018.09.006
Vancouver
Schmidt A, Romano MMD, Marin Neto JA, Rao-Melacini P, Rassi A, Mattos A, Avezum Junior Á, Villena E, Sosa-Estani S, Bonilla R, Yusuf S, Morillo CA, Maciel BC. Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy [Internet]. Journal of the American Society of Echocardiography. 2019 ; 32( 2): 286-295.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.echo.2018.09.006
Artigo de periodico
Complete revascularization with multivessel PCI for myocardial infarction (2019)
Mehta, Shamir R; Wood, David A.; Storey, Robert F.; Mehran, Roxana; Bainey, Kevin R.; Nguyen, Helen; Meeks, Brandi; Di Pasquale, Giuseppe; López-Sendon, Jose; Marin Neto, José Antonio
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, REVASCULARIZAÇÃO MIOCÁRDICA, INFARTO DO MIOCÁRDIO, CONTENEDORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Shamir R et al. Complete revascularization with multivessel PCI for myocardial infarction. The New England Journal of Medicine, v. 380, n. 15, p. 1411-1421, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1907775. Acesso em: 15 nov. 2024.
APA
Mehta, S. R., Wood, D. A., Storey, R. F., Mehran, R., Bainey, K. R., Nguyen, H., et al. (2019). Complete revascularization with multivessel PCI for myocardial infarction. The New England Journal of Medicine, 380( 15), 1411-1421. doi:10.1056/NEJMoa1907775
NLM
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendon J, Marin Neto JA. Complete revascularization with multivessel PCI for myocardial infarction [Internet]. The New England Journal of Medicine. 2019 ; 380( 15): 1411-1421.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1907775
Vancouver
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendon J, Marin Neto JA. Complete revascularization with multivessel PCI for myocardial infarction [Internet]. The New England Journal of Medicine. 2019 ; 380( 15): 1411-1421.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1907775
Artigo de periodico
Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the american heart association (2018)
Nunes, Maria Carmo Pereira; Beaton, Andrea; Acquatella, Harry; Bern, Caryn; Bolger, Ann F.; Echeverría, Luis E.; Dutra, Walderez O.; Gascon, Joaquim; Morillo, Carlos A.; Oliveira-Filho, Jamary; Ribeiro, Antonio Luiz Pinho; Marin Neto, José Antonio
Source: Circulation. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, MIOCARDIOPATIA CONGESTIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Maria Carmo Pereira et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the american heart association. Circulation, v. 138, n. 12, p. e169-e209, 2018Tradução . . Disponível em: https://doi.org/10.1161/cir.0000000000000599. Acesso em: 15 nov. 2024.
APA
Nunes, M. C. P., Beaton, A., Acquatella, H., Bern, C., Bolger, A. F., Echeverría, L. E., et al. (2018). Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the american heart association. Circulation, 138( 12), e169-e209. doi:10.1161/cir.0000000000000599
NLM
Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverría LE, Dutra WO, Gascon J, Morillo CA, Oliveira-Filho J, Ribeiro ALP, Marin Neto JA. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the american heart association [Internet]. Circulation. 2018 ; 138( 12): e169-e209.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1161/cir.0000000000000599
Vancouver
Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverría LE, Dutra WO, Gascon J, Morillo CA, Oliveira-Filho J, Ribeiro ALP, Marin Neto JA. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the american heart association [Internet]. Circulation. 2018 ; 138( 12): e169-e209.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1161/cir.0000000000000599
Artigo de periodico
Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) (2018)
Acquatella, Harry; Asch, Federico M.; Barbosa, Marcia M.; Barros, Marcio; Bern, Caryn; Cavalcante, Joao L.; Echeverria Correa, Luis Eduardo; Lima, Joao; Marcus, Rachel; Marin Neto, José Antonio; Migliore, Ricardo; Milei, Jose; Morillo, Carlos A.; Nunes, Maria Carmo Pereira; Vieira, Marcelo Luiz Campos; Viotti, Rodolfo
Source: Journal of the American Society of Echocardiography. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, MIOCARDIOPATIA CONGESTIVA, ANEURISMA, VENTRÍCULO CARDÍACO, ECOCARDIOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ACQUATELLA, Harry et al. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC). Journal of the American Society of Echocardiography, v. 31, n. 1, p. 3-25, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.echo.2017.10.019. Acesso em: 15 nov. 2024.
APA
Acquatella, H., Asch, F. M., Barbosa, M. M., Barros, M., Bern, C., Cavalcante, J. L., et al. (2018). Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC). Journal of the American Society of Echocardiography, 31( 1), 3-25. doi:10.1016/j.echo.2017.10.019
NLM
Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, Echeverria Correa LE, Lima J, Marcus R, Marin Neto JA, Migliore R, Milei J, Morillo CA, Nunes MCP, Vieira MLC, Viotti R. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) [Internet]. Journal of the American Society of Echocardiography. 2018 ; 31( 1): 3-25.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.echo.2017.10.019
Vancouver
Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, Echeverria Correa LE, Lima J, Marcus R, Marin Neto JA, Migliore R, Milei J, Morillo CA, Nunes MCP, Vieira MLC, Viotti R. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) [Internet]. Journal of the American Society of Echocardiography. 2018 ; 31( 1): 3-25.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.echo.2017.10.019
Artigo de periodico
Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mm Hg target? (2016)
Lonn, Eva M.; Yusuf, Salim; Marin Neto, José Antonio
Source: Circulation. Unidade: FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO, FATORES DE RISCO, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva M. e YUSUF, Salim e MARIN NETO, José Antonio. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mm Hg target?. Circulation, v. 134, n. 18, p. 1311-1313, 2016Tradução . . Disponível em: https://doi.org/10.1161/circulationaha.116.023264. Acesso em: 15 nov. 2024.
APA
Lonn, E. M., Yusuf, S., & Marin Neto, J. A. (2016). Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mm Hg target? Circulation, 134( 18), 1311-1313. doi:10.1161/circulationaha.116.023264
NLM
Lonn EM, Yusuf S, Marin Neto JA. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to<120/80 mm Hg target? [Internet]. Circulation. 2016 ; 134( 18): 1311-1313.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1161/circulationaha.116.023264
Vancouver
Lonn EM, Yusuf S, Marin Neto JA. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to<120/80 mm Hg target? [Internet]. Circulation. 2016 ; 134( 18): 1311-1313.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1161/circulationaha.116.023264
Artigo de periodico
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease (2016)
Lonn, Eva M.; Marin Neto, José Antonio; Jung, Hyejung; Dagenais, Gilles; Yusuf, Salim
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO, FARMACOTERAPIA, HIPOTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva M. et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, v. 374, n. 21, p. 2009-2020, 2016Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1600175. Acesso em: 15 nov. 2024.
APA
Lonn, E. M., Marin Neto, J. A., Jung, H., Dagenais, G., & Yusuf, S. (2016). Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, 374( 21), 2009-2020. doi:10.1056/NEJMoa1600175
NLM
Lonn EM, Marin Neto JA, Jung H, Dagenais G, Yusuf S. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2009-2020.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1600175
Vancouver
Lonn EM, Marin Neto JA, Jung H, Dagenais G, Yusuf S. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2009-2020.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1600175
Artigo de periodico
Cholesterol lowering in intermediate-risk persons without cardiovascular disease (2016)
Yusuf, S.; Marin Neto, José Antonio; Gao, P.; Diaz, R.; Lonn, E.
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR), ADESÃO À MEDICAÇÃO, HIPERCOLESTEROLEMIA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUSUF, S. et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, v. 374, n. 21, p. 2021-2031, 2016Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1600176. Acesso em: 15 nov. 2024.
APA
Yusuf, S., Marin Neto, J. A., Gao, P., Diaz, R., & Lonn, E. (2016). Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, 374( 21), 2021-2031. doi:10.1056/NEJMoa1600176
NLM
Yusuf S, Marin Neto JA, Gao P, Diaz R, Lonn E. Cholesterol lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2021-2031.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1600176
Vancouver
Yusuf S, Marin Neto JA, Gao P, Diaz R, Lonn E. Cholesterol lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2021-2031.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1600176
Artigo de periodico
Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics (2016)
Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro; Chazova, Irina; Dans, Antonio; Diaz, Rafael; Fodor, George J.; Held, Claes; Jansky, Petr; Keltai, Matyas; Keltai, Katalin; kunti, Kamlesh; Kim, Jae-Hyung; Leiter, Lawrence; Lewis, Basil; Liu, Lisheng; Lopez-Jaramillo, Patricio; Pais, Prem; Parkhomenko, Alexandr; Peters, Ron J. G; Piegas, Leopoldo S; Reid, Christopher M; Sliwa, Karen; Toff, William D; Varigos, John; Xavier, Denis; Yusoff, Khalid; Zhu, Jun; Dagenais, Gilles; Yusuf, Salim; Marin Neto, José Antonio
Source: Canadian Journal of Cardiology. Unidade: FMRP
Subjects: RECEPTORES DE ANGIOTENSINA, PRESSÃO SANGUÍNEA, DOENÇAS CARDIOVASCULARES, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva et al. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, v. 32, n. 3, p. 311-318, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.cjca.2015.07.001. Acesso em: 15 nov. 2024.
APA
Lonn, E., Bosch, J., Pogue, J., Avezum, A., Chazova, I., Dans, A., et al. (2016). Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, 32( 3), 311-318. doi:10.1016/j.cjca.2015.07.001
NLM
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Vancouver
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Artigo de periodico
Blood-pressure and cholesterol lowering in persons without cardiovascular disease (2016)
Yusuf, Salim; Marin Neto, José Antonio; Diaz, Rafael; Dans, Antonio; Dagenais, Gilles
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR), ADESÃO À MEDICAÇÃO, HIPERTENSÃO, COLESTEROL, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUSUF, Salim et al. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. New England Journal of Medicine, v. 374, n. 21, p. 2032-2043, 2016Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1600177. Acesso em: 15 nov. 2024.
APA
Yusuf, S., Marin Neto, J. A., Diaz, R., Dans, A., & Dagenais, G. (2016). Blood-pressure and cholesterol lowering in persons without cardiovascular disease. New England Journal of Medicine, 374( 21), 2032-2043. doi:10.1056/NEJMoa1600177
NLM
Yusuf S, Marin Neto JA, Diaz R, Dans A, Dagenais G. Blood-pressure and cholesterol lowering in persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2032-2043.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1600177
Vancouver
Yusuf S, Marin Neto JA, Diaz R, Dans A, Dagenais G. Blood-pressure and cholesterol lowering in persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2032-2043.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1600177
Artigo de periodico-carta/editorial
Benznidazole for chronic Chagas’ cardiomyopathy. [Carta] (2016)
Hamers, Raph L.; Gool, Tom van; Goorhuis, Abraham; Cordeiro, Marco Aurélio Santos; Urbina, Julio A.; Gascon, Joaquim; Ribeiro, Isabela; Morillo, Carlos A.; Marin Neto, José Antonio; Avezum, Álvaro
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: MIOCARDIOPATIA CHAGÁSICA, DOENÇA DE CHAGAS, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAMERS, Raph L. et al. Benznidazole for chronic Chagas’ cardiomyopathy. [Carta]. New England Journal of Medicine. Waltham: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1056/nejmc1514453. Acesso em: 15 nov. 2024. , 2016
APA
Hamers, R. L., Gool, T. van, Goorhuis, A., Cordeiro, M. A. S., Urbina, J. A., Gascon, J., et al. (2016). Benznidazole for chronic Chagas’ cardiomyopathy. [Carta]. New England Journal of Medicine. Waltham: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1056/nejmc1514453
NLM
Hamers RL, Gool T van, Goorhuis A, Cordeiro MAS, Urbina JA, Gascon J, Ribeiro I, Morillo CA, Marin Neto JA, Avezum Á. Benznidazole for chronic Chagas’ cardiomyopathy. [Carta] [Internet]. New England Journal of Medicine. 2016 ; 374( 2): 188-190.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/nejmc1514453
Vancouver
Hamers RL, Gool T van, Goorhuis A, Cordeiro MAS, Urbina JA, Gascon J, Ribeiro I, Morillo CA, Marin Neto JA, Avezum Á. Benznidazole for chronic Chagas’ cardiomyopathy. [Carta] [Internet]. New England Journal of Medicine. 2016 ; 374( 2): 188-190.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/nejmc1514453
Artigo de periodico
Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy (2015)
Morillo, Carlos A.; Marin Neto, José Antonio; Avezum, Álvaro; Sosa-Estani, Sergio; Rassi Júnior, Anis; Rosas, Fernando; Villena, Erick; Quiroz, Roberto; Bonilla, Rina; Britto, Constança; Guhl, Felipe; Velázquez, Elsa; Bonilla, Laura; Meeks, Brandi; Rao-Melacini, Purnima; Pogue, Janice; Mattos, Antônio; Lazdins, Janis; Rassi, Anis; Connolly, Stuart J.; Yusuf, Salim; Schmidt, André
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: MIOCARDIOPATIA CHAGÁSICA, TERAPÊUTICA MÉDICA, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORILLO, Carlos A. et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. The New England Journal of Medicine, v. 373, n. 14, p. 1295-1306, 2015Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1507574. Acesso em: 15 nov. 2024.
APA
Morillo, C. A., Marin Neto, J. A., Avezum, Á., Sosa-Estani, S., Rassi Júnior, A., Rosas, F., et al. (2015). Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. The New England Journal of Medicine, 373( 14), 1295-1306. doi:10.1056/NEJMoa1507574
NLM
Morillo CA, Marin Neto JA, Avezum Á, Sosa-Estani S, Rassi Júnior A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velázquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Schmidt A. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy [Internet]. The New England Journal of Medicine. 2015 ; 373( 14): 1295-1306.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1507574
Vancouver
Morillo CA, Marin Neto JA, Avezum Á, Sosa-Estani S, Rassi Júnior A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velázquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Schmidt A. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy [Internet]. The New England Journal of Medicine. 2015 ; 373( 14): 1295-1306.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1507574
Artigo de periodico
Ezetimibe added to statin therapy after acute coronary syndromes (2015)
Cannon, Christopher P.; Blazing, Michael A.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer A.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; Ferrari, Gaetano M. De; Ruzyllo, Witold; De Lucca, Paul; Im, KyungAh; Bohula, Erin A.; Reist, Craig; Wiviott, Stephen D.; Tershakovec, Andrew M.; Musline, Thomas A.; Braunwald, Eugene; Califf, Robert M.; Marin Neto, José Antonio; Schmidt, André
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: SÍNDROME CORONARIANA AGUDA, TERAPÊUTICA MÉDICA, COLESTEROL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANNON, Christopher P. et al. Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, v. 372, n. 25, p. 2387-2397, 2015Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1410489. Acesso em: 15 nov. 2024.
APA
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., et al. (2015). Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, 372( 25), 2387-2397. doi:10.1056/NEJMoa1410489
NLM
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1410489
Vancouver
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa1410489
Artigo de periodico
Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study (2014)
Leong, Darryl P.; Smyth, Andrew; Teo, Koon K.; McKee, Martin; Rangarajan, Sumathy; Pais, Prem; Liu, Lisheng; Anand, Sonia S.; Yusuf, Salim; Marin Neto, José Antônio
Source: Circulation. Unidade: FMRP
Subjects: ÁLCOOL, EPIDEMIOLOGIA, INFARTO DO MIOCÁRDIO, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEONG, Darryl P. et al. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study. Circulation, v. 130, n. 5, p. 390-398, 2014Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.113.007627. Acesso em: 15 nov. 2024.
APA
Leong, D. P., Smyth, A., Teo, K. K., McKee, M., Rangarajan, S., Pais, P., et al. (2014). Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study. Circulation, 130( 5), 390-398. doi:10.1161/CIRCULATIONAHA.113.007627
NLM
Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, Liu L, Anand SS, Yusuf S, Marin Neto JA. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study [Internet]. Circulation. 2014 ; 130( 5): 390-398.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.113.007627
Vancouver
Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, Liu L, Anand SS, Yusuf S, Marin Neto JA. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study [Internet]. Circulation. 2014 ; 130( 5): 390-398.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.113.007627

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration